Recreating kidney progenitors from pluripotent cells

Minoru Takasato1, Barbara Maier, Melissa H Little

  • 1Division of Molecular Genetics and Development, Institute for Molecular Biosciences, The University of Queensland, Brisbane, QLD, 4072, Australia.

Insights

Generating kidney cells from human pluripotent cells is difficult but essential for regenerative medicine. This review explores embryonic kidney development to guide the creation of kidney cells from pluripotent stem cells.

Area of Science:

  • Regenerative Medicine
  • Developmental Biology
  • Stem Cell Biology

Background:

  • Human pluripotent cells offer a potential source for cell therapies and bioengineering.
  • Directing differentiation of pluripotent cells into specific cell types, like renal cells, remains a significant challenge.
  • Recreating the kidney requires generating multiple distinct renal cell types, complicating in vitro efforts.

Purpose of the Study:

  • To review the embryonic development of kidney cells.
  • To assess progress in generating nephron progenitors and mature renal derivatives from pluripotent cells.
  • To bridge developmental biology insights with stem cell applications for kidney regeneration.

Main Methods:

  • Review of existing literature on embryonic kidney development.
  • Analysis of studies on directed differentiation of pluripotent stem cells towards renal lineages.
  • Synthesis of knowledge regarding cell specification and differentiation pathways.

Main Results:

  • Understanding embryonic kidney specification provides a roadmap for directed differentiation.
  • Progress has been made in generating nephron progenitors and some mature renal derivatives.
  • Challenges persist in replicating the full complexity of kidney cell types and structures.

Conclusions:

  • Embryonic kidney development provides crucial insights for stem cell-based kidney bioengineering.
  • Further research is needed to overcome challenges in generating diverse renal cell types from pluripotent sources.
  • Translating developmental knowledge holds promise for future cellular therapies for kidney disease.